Incidence of cutaneous melanoma among non-Hispanic Whites, Hispanics, Asians, and Blacks: An analysis of California Cancer Registry Data, 1988-93

Cancer Causes and Control

Volumn 8, Issue 2, 1997, Pages 246-252

  Cress, Rosemary D ^a,b   Holly, Elizabeth A ^c,d  

^a Cancer Surveillance Program   (United States)

^b PUBLIC HEALTH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

incidence; melanoma; race; site; United States

Indexed keywords

ARTICLE; CANCER INCIDENCE; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; RACE; SKIN CANCER; UNITED STATES;

AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; ASIAN CONTINENTAL ANCESTRY GROUP; CALIFORNIA; COHORT STUDIES; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; INCIDENCE; MALE; MELANOMA; REGISTRIES; RISK FACTORS; SEX DISTRIBUTION; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 0030889601     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018432632528     Document Type: Article

References (32)

1. Kosary C, Ries L, Miller B, et al. SEER Cancer Statistics Review, 1973-1992: Tables and Graphs. Bethesda MD (USA): National Cancer Institute, 1995.
2. Perkins C, Morris C, Wright W. Cancer Incidence and Mortality in California by Race/ethnicity, 1988-1993. Sacramento, CA (USA): California Department of Health Services, Cancer Surveillance Section, 1996.
3. Percy C, Van Holten V, Muir C, eds. International Classification of Diseases for Oncology, Second Edition. Geneva, Switzerland: World Health Organization, 1990.
4. Shambaugh E, Weiss ME. Summary Staging Guide for the Cancer Surveillance, Epidemiology and End Results Reporting (SEER) Program. Bethesda, MD (USA): U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, 1986:
5. Breslow N, Day N, eds. Statistical Methods in Cancer Research. Vol. 1. The Analysis of Case-control Studies. Lyon, France: International Agency for Research on Cancer, 1980.
6. SAS Institute Inc. SAS/STAT User's Guide, Version 6, Fourth Edition, Volume 2. (4 ed.) Cary, NC (USA): SAS Institute Inc., 1990.
7. Young JJ, Percy C, Asire A. Surveillance, Epidemiology, and End Results: Incidence and Mortality Data, 1973-77. Bethesda, MD (USA): U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, 1981.
8. Karagas MR, Thomas DB, Roth GJ, Johnson LK, Weiss NL. The effects of changes in health care delivery on the reported incidence of cutaneous melanoma in western Washington state. Am J Epidemiol 1991; 133: 58-62.
9. Koh HK, Geller A, Miller DR, Clapp RW, Lew RA. Underreporting of cutaneous melanoma in cancer registries nationwide. J Am Acad Dermatol 1992; 27: 1035-6.
10. Elder DE. Skin cancer: melanoma and other specific non-melanoma skin cancers. Cancer 1995; 75: 245-56.
11. Bureau of the Census. Assessment of Accuracy of Adjusted Versus Unadjusted 1990 Census Base for Use in Intercensul Estimates: Report of the Committee on Adjustment of Postcensul Estimates. Washington, DC:Bureau of the Census, 1992.
12. Trapido EJ, Valdez RB, Obeso JL, Strickman-Stein NAR, Perez-Stable EJ. Epidemiology of cancer among Hispanics in the United States. JNCI Monogr 1995; 18: 17-28.
13. Stewart S, Glaser S, Horn-Ross P, West D. SEER Study of Methods to Classify Hispanic Cancer Patients (Final Report: Contract N01-CN-05224). Union City, CA (USA): Northern California Cancer Center, 1993:
14. Chang S, Kerlikowske K, Napoles-Springer A, Posner S, Sickles E, Perez-Stable E. Racial differences in timeliness of follow-up after abnormal screening mammography. Cancer 1996; 78: 1395-402.
15. Dwyer P, MacKie R, Watt D, Aitchison T. Plantar malignant melanoma in a white Caucasian population. Br J Derm 1993; 128: 115-20.
16. Coleman WP, Loria PR, Reed RJ, Krementz ET. Acral lentiginous melanoma. Arch Dermatol 1980; 116: 773-6.
17. Vayer A, Lefor A. Cutaneous melanoma in African-Americans. South Med J 1993; 86: 181-2.
18. Jimbow K, Takahashi H, Miura S, Ikeda S, Kukita A. Biological behavior and natural course of acral malignant melanoma: clinical and histologic features and prognosis of palmoplantar, subungual, and other acral malignant melanomas. Am J Dermatopathol 1984; 6(Suppl 1): 43-53.
19. Pantoja E, Llobet RE, Roswit B. Melanomas of the lower extremity among native Puerto Ricans. Cancer 1976; 38: 1420-3.
20. Reintgen D, McCarty K, Cox E, Seigler H. Malignant melanoma in the American black. Curr Surg 1983; 40: 215-7.
21. Black WC, Palmer C, Varsa E, Bartow S, Foucar E, Burgdorf W. The New Mexico melanoma registry: a model of a statewide cooperative program. Am J Dermatopathol 1987; 9: 10-4.
22. Schwartz SM, Armstrong BK, Weiss NS. Seasonal variation in the incidence of cutaneous malignant melanoma: an analysis by body site and histologic type. Am J Epidemiol 1987; 126: 104-11.
23. Heenan PJ, Armstrong BK, English DR, Holman CD. Pathological and epidemiological variants of cutaneous malignant melanoma. Pigment Cell Res 1987; 8: 107-46.
24. Elwood J, Gallagher R, Worth A, Wood W, Pearson J. Etiological differences between subtypes of cutaneous malignant melanoma: Western Canada Melanoma Study. JNCI 1987; 78: 37-44.
25. Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JK. Cutaneous melanoma in women. II. Phenotypic characteristics and other host-related factors. Am J Epidemiol 1995; 141: 934-42.
26. Thorn M, Ponten F, Bergstrom R, Sparen P, Adami HO. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden. JNCI 1994; 86: 761-9.
27. Koh HK, Adame N, Geller AC, Clapp RW, Miller DR, Lew RA. Cancer-registry data on melanomas [Letter]. N Engl J Med 1990; 323: 921-2.
28. California Department of Health Services. Cancer Reporting in California: Abstracting and Coding Procedures for Hospitals. California Cancer Reporting System Standards, Volume 1, Third Edition. Sacramento, CA (USA): California Cancer Registry, Data Standards and Assessment Unit, 1995:
29. Gallagher R, Elwood J, Hill G. Risk factors for cutaneous malignant melanoma: The Western Canada Melanoma Study. Recent Res Cancer Res 1986; 102: 38-55.
30. Osterlind A, Tucker M, Hou-Jensen K, Stone B, Engholm G, Jensen O. The Danish case-control study of cutaneous malignant melanoma. I. Importance of host factors. Int J Cancer 1988; 42: 200-6.
31. Holly E, Aston D, Ahn D, Kristiansen J. Cutaneous melanoma in women: I. Exposure to sunlight, ability to tan, and other UV related risk factors. Am J Epidemiol 1995; 141: 923-33.
32. Armstrong B, Kricker A. How much melanoma is caused by sun exposure? Melanoma Res 1993; 3: 395-401.